These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21524910)

  • 1. Research on PEGylation of porcine prothrombin for improving biostability and reducing animal immunogenicity.
    Zhou JG; Chen YM
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3268-72. PubMed ID: 21524910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity.
    Huang Z; Ni C; Chu Y; Wang S; Yang S; Wu X; Wang X; Li X; Feng W; Lin S
    J Biotechnol; 2009 Jul; 142(3-4):242-9. PubMed ID: 19477206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.
    Wang YJ; Hao SJ; Liu YD; Hu T; Zhang GF; Zhang X; Qi QS; Ma GH; Su ZG
    J Control Release; 2010 Aug; 145(3):306-13. PubMed ID: 20427020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli.
    Wang YJ; Liu YD; Chen J; Hao SJ; Hu T; Ma GH; Su ZG
    Int J Pharm; 2010 Feb; 386(1-2):156-64. PubMed ID: 19932158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full-length cDNA cloning and protein three-dimensional structure modeling of porcine prothrombin.
    Chen Y; Tan W; Lu X; Lu Y; Qin S; Li S; Zeng Y; Bu H; Li Y; Cheng J
    Blood Cells Mol Dis; 2007; 38(2):93-9. PubMed ID: 17188533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced protection of modified human acidic fibroblast growth factor with polyethylene glycol against ischemia/reperfusion-induced retinal damage in rats.
    Huang Z; Zheng Q; Wu X; Su Z; Xu H; Tan Y; Feng W; Li X; Cai L
    Toxicol Lett; 2007 Apr; 170(2):146-56. PubMed ID: 17416472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5'-phosphate supplementation.
    Sun X; Yang Z; Li S; Tan Y; Zhang N; Wang X; Yagi S; Yoshioka T; Takimoto A; Mitsushima K; Suginaka A; Frenkel EP; Hoffman RM
    Cancer Res; 2003 Dec; 63(23):8377-83. PubMed ID: 14678999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).
    Youn YS; Lee KC
    Bioconjug Chem; 2007; 18(2):500-6. PubMed ID: 17243755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates.
    Yang Z; Wang J; Lu Q; Xu J; Kobayashi Y; Takakura T; Takimoto A; Yoshioka T; Lian C; Chen C; Zhang D; Zhang Y; Li S; Sun X; Tan Y; Yagi S; Frenkel EP; Hoffman RM
    Cancer Res; 2004 Sep; 64(18):6673-8. PubMed ID: 15374983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEGylation of alpha-momorcharin: synthesis and characterization of novel anti-tumor conjugates with therapeutic potential.
    Bian X; Shen F; Chen Y; Wang B; Deng M; Meng Y
    Biotechnol Lett; 2010 Jul; 32(7):883-90. PubMed ID: 20238144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein carboxyl amidation increases the potential extent of protein polyethylene glycol conjugation.
    Li S; Yang Z; Sun X; Tan Y; Yagi S; Hoffman RM
    Anal Biochem; 2004 Jul; 330(2):264-71. PubMed ID: 15203332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro refolding of PEGylated lipase.
    Kim MY; Kwon JS; Kim HJ; Lee EK
    J Biotechnol; 2007 Aug; 131(2):177-9. PubMed ID: 17683821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenyl linker-induced dense PEG conformation improves the efficacy of C-terminally monoPEGylated staphylokinase.
    Xue X; Li D; Yu J; Ma G; Su Z; Hu T
    Biomacromolecules; 2013 Feb; 14(2):331-41. PubMed ID: 23301655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylation of cholecystokinin prolongs its anorectic effect in rats.
    León-Tamariz F; Verbaeys I; Van Boven M; De Cuyper M; Buyse J; Clynen E; Cokelaere M
    Peptides; 2007 May; 28(5):1003-11. PubMed ID: 17379357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of therapeutic potentials of site-specific PEGylated glucagon-like peptide-1 isomers as a type 2 anti-diabetic treatment: Insulinotropic activity, glucose-stabilizing capability, and proteolytic stability.
    Youn YS; Chae SY; Lee S; Jeon JE; Shin HG; Lee KC
    Biochem Pharmacol; 2007 Jan; 73(1):84-93. PubMed ID: 17054919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein.
    Meng F; Manjula BN; Smith PK; Acharya SA
    Bioconjug Chem; 2008 Jul; 19(7):1352-60. PubMed ID: 18572961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.